How I Manage: Chronic Myeloid Leukemia Clinical Oncology News The tyrosine kinase inhibitors (TKIs) have irrevocably changed the care of chronic myeloid leukemia (CML) patients, dramatically changing the natural history of this disease. 1-4 With multiple TKIs available, we now have an “embarrassment of riches” in ...
Medivo Launches Free Mobile App for Monitoring Chronic Myeloid Leukemia... MarketWatch (press release) NEW YORK, May 15, 2013 (BUSINESS WIRE) -- Medivo Inc., a health monitoring platform that regularly connects doctors, consumers and clinical labs, today announced the launch of CML Monitor, a free mobile app for people living with chronic myelogenous ...
Faith, family help Brooks fight leukemia ThisWeekNews Doctors had at first decided a bone marrow transplant was too risky, after Mrs. Brooks was diagnosed with chronic myeloid leukemia (CML) in January 2007. Mr. Brooks said his wife was taking a number of chemotherapy drugs over the past six years, but ...
Nilotinib Associated With Increased Peripheral Artery Disease Rate in CML Cancer Network Both a retrospective cohort analysis and a prospective study found higher rates of peripheral artery occlusive disease ( PAOD ) among patients with chronic myeloid leukemia ( CML ) who received nilotinib than in those who received imatinib. Both new ...
Research and Markets: EpiCast Report: Chronic Myeloid Leukemia... Business Wire (press release) Chronic Myeloid Leukemia (CML) is a rare cancer of the white blood cells characterized by increased and unregulated growth of myeloid cells originating in the bone marrow that invade the blood and potentially other organs, depending on the phase of the ...
EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022 Wall Street Journal Chronic Myeloid Leukemia (CML) is a rare cancer of the white blood cells characterized by increased and unregulated growth of myeloid cells originating in the bone marrow that invade the blood and potentially other organs, depending on the phase of the ...
